PIEDMONT INVESTMENT ADVISORS INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
PIEDMONT INVESTMENT ADVISORS INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$464,000
-13.4%
4,657
-0.2%
0.02%
-5.3%
Q4 2019$536,000
-21.3%
4,664
-13.6%
0.02%
-26.9%
Q3 2019$681,000
-13.6%
5,400
-17.5%
0.03%
-18.8%
Q2 2019$788,000
+209.0%
6,545
+124.5%
0.03%
+220.0%
Q1 2019$255,000
+12.3%
2,916
+28.5%
0.01%
-9.1%
Q4 2018$227,000
+170.2%
2,270
+143.3%
0.01%
+175.0%
Q2 2018$84,000
-90.0%
933
-91.8%
0.00%
-81.8%
Q1 2018$836,000
+32.5%
11,424
+5.2%
0.02%
+69.2%
Q4 2017$631,000
+22.8%
10,857
-5.3%
0.01%
+18.2%
Q3 2017$514,000
+14.7%
11,459
+1.0%
0.01%
+10.0%
Q2 2017$448,00011,3440.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders